MedPath

ACID CONCENTRATE RZ265C

ACID CONCENTRATE RZ265C

Discontinued
DIN Number

02230081

Drug Class

Human

Market Date

Jan 29, 1997

Company
HC

genpharm ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02230081
AIG Number0617386379
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormLiquid
Route of AdministrationHaemodialysis
AHFS Classification40:34.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

ACETIC ACIDActive
Strength: 6.756 G / L
Monograph: ACETIC ACID
CALCIUM CHLORIDEActive
Strength: 8.27 G / L
Monograph: CALCIUM CHLORIDE
DEXTROSEActive
Strength: 49.5 G / L
Monograph: DEXTROSE
MAGNESIUM CHLORIDEActive
Strength: 3.431 G / L
Monograph: MAGNESIUM CHLORIDE
POTASSIUM CHLORIDEActive
Strength: 5.032 G / L
Monograph: POTASSIUM CHLORIDE
SODIUM CHLORIDEActive
Strength: 276.1 G / L
Monograph: SODIUM CHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.